AKT1 and acute myeloid leukemia: We believe that the drugs may act by similar mechanisms as celastrol, which blocks MYB activity in AML (12), but they may also regulate MYB expression through inhibition of for example JAK/STAT and/or PI3K/AKT/mTOR signaling.